Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bigumal
2. Chlorguanid
3. Chloriguane
4. Chloroguanide
5. Chloroguanide Hydrochloride
6. Hydrochloride, Chloroguanide
7. Hydrochloride, Proguanil
8. Paludrin
9. Proguanil
10. Proguanil Hydrochloride
1. Proguanil Hydrochloride
2. Chloroguanide Hydrochloride
3. 637-32-1
4. Diguanyl
5. Chlorguanide Hydrochloride
6. Chloroquanil
7. Proguanil Hcl
8. Proguanilhydrochloride
9. 1-(p-chlorophenyl)-5-isopropylbiguanide Hydrochloride
10. Drinupal
11. Guanatol
12. Palusil
13. Gw Ah7673a
14. Tirian Hydrochloride
15. Proguanil (hydrochloride)
16. 336u50
17. Palusil Hydrochloride
18. Drinupal Hydrochloride
19. Guanatol Hydrochloride
20. Gwah7673a
21. Gw-ah7673a
22. R71y86m0wt
23. M-4888
24. Nsc-12977
25. Nsc-26614
26. Rp-3359
27. Bigumalum
28. Sn-12837
29. 3359 Rp
30. Dsstox_cid_27756
31. Dsstox_rid_82533
32. Dsstox_gsid_47776
33. 336-u-50
34. Sn 12,837
35. 1-(4-chlorophenyl)-5-isopropylbiguanide Hydrochloride
36. M 4888
37. Chloroguanidine Hydrochloride
38. Imidodicarbonimidic Diamide, N-(4-chlorophenyl)-n'-(1-methylethyl)-,monohydrochloride
39. N-(4-chlorophenyl)-n(sup5)-isopropyldiguanide Hydrochloride
40. Ncgc00016528-01
41. Cas-637-32-1
42. Einecs 211-283-7
43. Nsc 12977
44. Nsc 26614
45. Unii-r71y86m0wt
46. Sr-05000001973
47. Proguanil Hydrochloride [usan]
48. 1-(4-chlorophenyl)-3-(n-propan-2-ylcarbamimidoyl)guanidine;hydrochloride
49. Proguanil Chloride
50. Paludrine (tn)
51. Proguanil Hydrochloride [usan:usp]
52. N-4-chlorophenyl-n(sup 5)-isopropyldiguanide Hydrochloride
53. Proguanili Hydrochloridum
54. Biguanide, 1-(p-chlorophenyl)-5-isopropyl-, Monohydrochloride
55. Imidodicarbonimidic Diamide, N-(4-chlorophenyl)-n'-(1-methylethyl)-, Monohydrochloride
56. Schembl218859
57. Ambz0378
58. Proguanil For System Suitability
59. Chembl1201059
60. Dtxsid7047776
61. Hy-b0806a
62. Hms1571g19
63. Pharmakon1600-01504211
64. Proguanil Hydrochloride (jan/usp)
65. Tox21_110476
66. Ccg-39555
67. Nsc758688
68. Proguanil Hydrochloride [jan]
69. Akos024255720
70. Tox21_110476_1
71. Am85857
72. Chlorguanide Hydrochloride [mi]
73. Hs-0102
74. Nsc-758688
75. Proguanil Hydrochloride [mart.]
76. Proguanil Hydrochloride [usp-rs]
77. Proguanil Hydrochloride [who-dd]
78. Proguanil Hydrochloride [who-ip]
79. Ncgc00016528-05
80. Proguanil Hydrochloride, >=95% (hplc)
81. Cs-0031267
82. Proguanil Hydrochloride [orange Book]
83. Proguanil Hydrochloride [ep Monograph]
84. D02487
85. Proguanil Hydrochloride [usp Monograph]
86. Malarone Component Proguanil Hydrochloride
87. Proguanili Hydrochloridum [who-ip Latin]
88. 637p321
89. A923181
90. Proguanil Hydrochloride Component Of Malarone
91. Sr-05000001973-3
92. W-109585
93. Malarone Pediatric Component Proguanil Hydrochloride
94. Proguanil Hydrochloride Component Of Malarone Pediatric
95. 1-(p-chlorophenyl)-5-isopropylbiguanide Monohydrochloride
96. Proguanil Hydrochloride, British Pharmacopoeia (bp) Reference Standard
97. Proguanil Hydrochloride, European Pharmacopoeia (ep) Reference Standard
98. Proguanil Hydrochloride, United States Pharmacopeia (usp) Reference Standard
99. (1e)-1-[amino-[(4-chlorophenyl)amino]methylidene]-2-propan-2-ylguanidine Hydrochloride
100. Proguanil For System Suitability, European Pharmacopoeia (ep) Reference Standard
101. Proguanil Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
102. Imidodicarbonimidic Diamide, N-(4-chlorophenyl)-n'-(1-methylethyl)-, Hydrochloride (1:1)
Molecular Weight | 290.19 g/mol |
---|---|
Molecular Formula | C11H17Cl2N5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 4 |
Exact Mass | 289.0861010 g/mol |
Monoisotopic Mass | 289.0861010 g/mol |
Topological Polar Surface Area | 88.8 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 292 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
Antimetabolites
Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Proguanil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Proguanil manufacturer or Proguanil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Proguanil manufacturer or Proguanil supplier.
PharmaCompass also assists you with knowing the Proguanil API Price utilized in the formulation of products. Proguanil API Price is not always fixed or binding as the Proguanil Price is obtained through a variety of data sources. The Proguanil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Paludrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Paludrine, including repackagers and relabelers. The FDA regulates Paludrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Paludrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Paludrine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Paludrine supplier is an individual or a company that provides Paludrine active pharmaceutical ingredient (API) or Paludrine finished formulations upon request. The Paludrine suppliers may include Paludrine API manufacturers, exporters, distributors and traders.
click here to find a list of Paludrine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Paludrine DMF (Drug Master File) is a document detailing the whole manufacturing process of Paludrine active pharmaceutical ingredient (API) in detail. Different forms of Paludrine DMFs exist exist since differing nations have different regulations, such as Paludrine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Paludrine DMF submitted to regulatory agencies in the US is known as a USDMF. Paludrine USDMF includes data on Paludrine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Paludrine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Paludrine suppliers with USDMF on PharmaCompass.
A Paludrine CEP of the European Pharmacopoeia monograph is often referred to as a Paludrine Certificate of Suitability (COS). The purpose of a Paludrine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Paludrine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Paludrine to their clients by showing that a Paludrine CEP has been issued for it. The manufacturer submits a Paludrine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Paludrine CEP holder for the record. Additionally, the data presented in the Paludrine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Paludrine DMF.
A Paludrine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Paludrine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Paludrine suppliers with CEP (COS) on PharmaCompass.
A Paludrine written confirmation (Paludrine WC) is an official document issued by a regulatory agency to a Paludrine manufacturer, verifying that the manufacturing facility of a Paludrine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Paludrine APIs or Paludrine finished pharmaceutical products to another nation, regulatory agencies frequently require a Paludrine WC (written confirmation) as part of the regulatory process.
click here to find a list of Paludrine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Paludrine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Paludrine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Paludrine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Paludrine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Paludrine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Paludrine suppliers with NDC on PharmaCompass.
Paludrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Paludrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Paludrine GMP manufacturer or Paludrine GMP API supplier for your needs.
A Paludrine CoA (Certificate of Analysis) is a formal document that attests to Paludrine's compliance with Paludrine specifications and serves as a tool for batch-level quality control.
Paludrine CoA mostly includes findings from lab analyses of a specific batch. For each Paludrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Paludrine may be tested according to a variety of international standards, such as European Pharmacopoeia (Paludrine EP), Paludrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Paludrine USP).